Sichuan Hebang Biotechnology Co Ltd (603077) — Cash Flow Quality Index
Sichuan Hebang Biotechnology Co Ltd (603077) has a Cash Flow Quality Index of 4.00x as of September 2025. Operating cash flow of CN¥165.40 Million exceeds net income of CN¥41.34 Million, indicating high earnings quality where cash backs reported profits. Explore investment intensity of Sichuan Hebang Biotechnology Co Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sichuan Hebang Biotechnology Co Ltd Cash Flow Quality Index (2009–2023)
Historical Cash Flow Quality Index for Sichuan Hebang Biotechnology Co Ltd across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Sichuan Hebang Biotechnology Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sichuan Hebang Biotechnology Co Ltd (2009–2023)
Year-by-year earnings quality comparison for Sichuan Hebang Biotechnology Co Ltd. For live market cap and the full company financial profile, see Sichuan Hebang Biotechnology Co Ltd (603077) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.16x | CN¥200.76 Million | CN¥1.28 Billion | ▼ -77.4% |
| 2022 | 0.69x | CN¥2.64 Billion | CN¥3.81 Billion | ▼ -34.2% |
| 2021 | 1.05x | CN¥3.20 Billion | CN¥3.03 Billion | ▼ -99.2% |
| 2020 | 126.77x | CN¥368.85 Million | CN¥2.91 Million | ▲ +39321.1% |
| 2019 | 0.32x | CN¥162.92 Million | CN¥506.61 Million | ▼ -89.8% |
| 2018 | 3.17x | CN¥944.39 Million | CN¥298.20 Million | ▲ +804.2% |
| 2017 | 0.35x | CN¥176.94 Million | CN¥505.19 Million | ▼ -80.4% |
| 2016 | 1.79x | CN¥575.26 Million | CN¥321.47 Million | ▼ -4.9% |
| 2015 | 1.88x | CN¥449.20 Million | CN¥238.73 Million | ▲ +517.6% |
| 2014 | 0.30x | CN¥204.67 Million | CN¥671.76 Million | ▲ +104.8% |
| 2013 | -6.32x | CN¥-407.48 Million | CN¥64.43 Million | ▼ -1669.4% |
| 2012 | 0.40x | CN¥134.96 Million | CN¥334.89 Million | ▼ -73.3% |
| 2011 | 1.51x | CN¥552.56 Million | CN¥366.28 Million | ▼ -22.1% |
| 2010 | 1.94x | CN¥330.77 Million | CN¥170.71 Million | ▲ +21.4% |
| 2009 | 1.60x | CN¥68.97 Million | CN¥43.22 Million | — |